These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 26648186

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Pfyffer G, Ruef C, Fehr J, Zbinden R, Calandra T, Bille J, FUNGINOS.
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [Abstract] [Full Text] [Related]

  • 7. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.
    Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F, French Mycosis Study Group.
    Antimicrob Agents Chemother; 2011 Feb; 55(2):532-8. PubMed ID: 21078946
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H, Xu YC, Hsueh PR.
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M, Deshpande LM, Messer SA, Rhomberg PR, Pfaller MA.
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M.
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
    Cretella D, Barber KE, King ST, Stover KR.
    J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A, Yazdanpanah S, Bakhtiari M, Fang W, Pan W, Mahmoudi S, Pakshir K, Daneshnia F, Boekhout T, Ilkit M, Perlin DS, Zomorodian K, Zand F.
    Med Mycol; 2021 May 04; 59(5):422-430. PubMed ID: 32692816
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF, Ahmad S, Khan Z.
    Sci Rep; 2020 Apr 10; 10(1):6238. PubMed ID: 32277126
    [Abstract] [Full Text] [Related]

  • 20. Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis.
    Locke JB, Pillar CM, Castanheira M, Carvalhaes CG, Andes D, Aram JA, Andrzejewski C, Bartizal K, Das AF, Sandison T, Thompson GR, Pappas PG.
    Antimicrob Agents Chemother; 2024 May 02; 68(5):e0158423. PubMed ID: 38526046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.